image/svg+xml
radiation nation
image/svg+xml
radiation nation

Radiation Oncology Online: How Do We Connect?

R
by
/
April 19, 2014

For those of us venturing online, it can seem vast and lonely. For radiation oncology, it’s hard also to know where to start without getting burned. How do we find others with similar interests?

In my opinion, the most productive networks are Twitter and LinkedIn. Twitter lets me connect with people I might not meet otherwise. LinkedIn is a professional social network with active groups discussing radiation oncology. The two are also a nice balance: brief, immediate but ephemeral (Twitter) with longer, more professional conversations (LinkedIn).

On Twitter, you can follow anyone. But they won’t ‘see’ you unless they follow back.  And you don’t have to post anything. Here is a partial list of radiation oncology groups on Twitter:

   Professional Organization         Twitter Handle
ASTRO@ASTRO_org
ESTRO@ESTRO_RT
CARO@caro_acro_ca
ASRT@ASRT
AAPM@aapmHQ
Oncology Nursing Society@oncologynursing
ARRO@ARRO_org
Royal College ANZ Radiologists@RadiologyRANZCR
NVRO@NVRO_NL
CAMRT/ACTRM@CAMRT_ACTRM
Radiation Leadership Institute (ACR)@RLI_ACR
Global Task Force on Radiotherapy for Cancer Control@GTFRCC 

Currently, the only radiation oncology department is the University of Toronto @UofTDRO. SDN Network  is more medical student/resident focused. Doximity is good if your interests is doctors only, but  I haven’t been active. There are only so many places you can spend your ‘free time’. Lots of radiation oncologists are now on Twitter and LinkedIn. But not everyone wants to be public about it.

For those that do, I have set up a directory for people that want to connect.   What else do we need to connect?

image/svg+xml
radiation nation
Radiation Nation is dedicated to a collaborative approach to sharing for all involved in the use of radiation medicine.
© 2024 Radiation Nation. All rights reserved.

Stay up to date

Join our email list to get updates when new episodes articles,
exclusive content, and more.